Comparable Company Analysis

Fundamental Analysis · intermediate · CC-BY-4.0

Comparable Company Analysis ("comps" or "trading comps") is a relative valuation methodology that estimates a company's value by benchmarking its financial metrics against those of similar publicly traded companies, using multiples such as EV/EBITDA, P/E, and EV/Revenue to derive an implied valuation range. It reflects the market's current pricing of comparable businesses and is a cornerstone of investment banking, equity research, and hedge fund fundamental analysis.

Key takeaways

• Comps provides a market-implied, relative valuation — it tells you what the market is paying for similar businesses today, not what a business is worth in absolute terms.
• The critical judgment is peer group selection: companies must be similar in business model, growth profile, margin structure, capital intensity, and end market exposure.
• EV/EBITDA is the most commonly used multiple for operationally stable businesses; P/E is preferred for financials; EV/Revenue suits high-growth companies with negative EBITDA.
• Comps must be 'cleaned' for non-recurring items, different fiscal year ends, and varying accounting choices before applying multiples.
• The analysis produces a valuation range rather than a point estimate; practitioners typically weight the 25th–75th percentile of comparable multiples.

Explanation

Comparable company analysis rests on the law of one price: in an efficient market, similar assets should trade at similar prices. The practical execution of this principle requires careful selection of truly comparable businesses and meticulous standardization of financial metrics.

The standard process begins with building the peer group. Analysts use SIC codes, GICS classifications, product segment descriptions, and industry knowledge to identify 6–15 comparables. Ideal comparables share the target's revenue model (recurring vs. transactional), end market, geography, margins, leverage, and growth trajectory. In practice, a perfect peer group rarely exists, particularly for diversified conglomerates or companies in niche industries — the analyst must disclose and justify the selection criteria.

Financial metrics are then standardized. Enterprise Value (EV) = Market Cap + Total Debt − Cash and Equivalents + Minority Interest + Preferred Equity. EBITDA is adjusted for non-recurring items (restructuring charges, impairments, legal settlements, stock-based compensation may or may not be included depending on convention). Metrics are typically calendarized to the same fiscal year-end for comparison, and both last-twelve-months (LTM) and forward-year (NTM) multiples are computed.

Key multiples and their typical ranges vary by sector. EV/EBITDA for mature industrial companies typically ranges from 8x to 12x; technology software companies might trade at 20x–40x NTM EBITDA. P/E ratios for S&P 500 companies have historically averaged 15x–18x, but growth companies may command 30x–50x. EV/Revenue is used for companies with negative or highly variable EBITDA — SaaS businesses might trade at 6x–12x NTM revenue depending on growth rate and net revenue retention.

The output of a comps analysis is typically a football field chart showing valuation ranges derived from different multiples and different statistical benchmarks (median, mean, 25th/75th percentile). This range is compared against current trading price to assess over/undervaluation and against DCF output to triangulate a final view.

Formula

Enterprise Value = Market Capitalization + Total Debt − Cash + Minority Interest + Preferred Equity

Example

An analyst values a specialty pharmaceutical company with $500 million in LTM EBITDA. The peer group of eight comparable pharma companies trades at EV/EBITDA multiples ranging from 9.5x to 16.2x, with a median of 12.8x and a mean of 12.4x. Applying the median of 12.8x to $500 million gives an implied EV of $6.4 billion. Subtracting net debt of $1.2 billion yields an implied equity value of $5.2 billion, or $52.00 per share on 100 million diluted shares — compared to the current trading price of $45.00, suggesting approximately 15.6% upside on a comps basis. The analyst cross-checks this against a DCF-derived value of $58.00 and precedent transaction multiples of 14x–18x, weighting all three methods to reach a final target of $54.00.

Related terms

Basis Cap Dupont Analysis Ebitda Enterprise Value Equity Hedge Fund Interest Coverage Ratio Leverage Net Debt Net Profit Margin Precedent Transaction Analysis